Evidence map›Paper›PMID 38418470›Full record

Observational studyScientific reports2024

Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.

Lucia Fratino, Jerry Polesel, Emilio Francesco Giunta, Marco Maruzzo, Sebastiano Buti, Mona Ali Hassan, Umberto Basso, Sara Elena Rebuzzi, Ugo De Giorgi, Marika Cinausero and 9 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Frailty and [Theranostics · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 12 institutions in 2 countries.

Lucia FratinoDepartment of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Jerry PoleselUnit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Emilio Francesco GiuntaDepartment of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Marco MaruzzoMedical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.
Sebastiano ButiOncology Unit, University Hospital of Parma, Parma, Italy.
Mona Ali HassanPortsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK.
Umberto BassoMedical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.
Sara Elena RebuzziMedical Oncology Unit, Ospedale San Paolo, Savona, Italy.
Ugo De GiorgiDepartment of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Marika CinauseroDepartment of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.
Helga LipariDivision of Medical Oncology, Cannizzaro Hospital, Catania, Italy.
Teresa GambaMedical Oncology, Mauriziano Hospital, Turin, Italy.
Davide BimbattiMedical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy.
Arianna DriDepartment of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.
Paola ErmacoraDepartment of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.
Francesca VignaniMedical Oncology, Mauriziano Hospital, Turin, Italy.
Giuseppe FornariniMedical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pasquale RescignoCandiolo Cancer Institute, FPO-IRCCS, SP142, km 3,95, 10060, Candiolo, Turin, Italy. Pasquale.rescigno@ircc.it.
Giuseppe Luigi BannaPortsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK.
Istituto Oncologico Veneto · ITA. O. Ordine Mauriziano di Torino · ITCentro di Riferimento Oncologico · ITIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITOspedale Santa Maria della Misericordia di Udine · ITPortsmouth Hospitals NHS Trust · GBCandiolo Cancer Institute · ITOspedale Cannizzaro · ITOspedale Policlinico San Martino · ITOspedale San Paolo · ITUniversity of Parma · ITUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Instrumental activities of daily living (IADL) are significant health indicators closely related to executive functions and able to detect mild cognitive impairment. A decline in IADL usually precedes ADL limitation, including taking medications, and may therefore predict a cognitive decline. We aimed to investigate the association of patients' IADL score with other clinical factors, with a particular focus on the presence of a caregiver, and the impact on adherence to androgen receptor pathway inhibitors (ARPIs) and survival outcomes within the Meet-URO 5-ADHERE study. It was a large prospective multicentre observational cohort study monitoring adherence to ARPIs in 234 metastatic castrate-resistant PC (mCRPC) patients aged ≥ 70. We observed an association between impaired IADL and lower geriatric G8 scores (p < 0.01), and lower adherence to ARPIs whether assessed by pill counting (p = 0.01) or self-reported by the patient himself (p = 0.03). The combination of an IADL < 6 and the absence of a caregiver resulted in a significantly high risk of non-adherence to the ARPIs at the multivariable analysis (HR 9.23, 95% confidence interval 2.28-37.43, p = 0.01). IADL alongside the geriatric G8 scales represent essential tools to identify frail and less auto-sufficient patients who are extremely vulnerable particularly if not supported by a caregiver and have the highest risk of nonadherence to ARPIs.

Indexed as

Activities of Daily LivingProstatic NeoplasmsAgedCaregiversHumansMaleProspective StudiesSelf Report

Identifiers

PMID38418470
PMCPMC10902368
OpenAlexW4392243057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.